Showing results (211-220 of 239) with videos related to
Sort By:
Pageof 24
Molecular Cancer Therapeutics|December 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele AmplificationAntonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, et al.Molecular Cancer Therapeutics|October 10, 2020
Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 AgonistJuan Manuel García-Martínez, Shirley Wang, Cordula Weishaeupl, et al.Cell Reports|April 13, 2022
Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genesAnna Köferle, Andreas Schlattl, Alexandra Hörmann, et al.Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.BMJ Open|February 22, 2018
Evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: study protocol for a randomised controlled trialTim Kirkpatrick, Charlotte Lennox, Rod Taylor, et al.Oncotarget|March 18, 2020
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasisStefanie Schlager, Carina Salomon, Sabine Olt, et al.Health Technology Assessment (Winchester, England)|May 9, 2026
Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluationMiriam J Johnson, Bronwen Williams, Catriona Keerie, et al.Journal of Medicinal Chemistry|February 12, 2019
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding FunctionsJohannes Popow, Heribert Arnhof, Gerd Bader, et al.Molecular Cancer Therapeutics|February 7, 2020
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor SurveillanceMarco H Hofmann, Rajeswaran Mani, Harald Engelhardt, et al.Pageof 24